4 Fig. S1 . Distribution of log-intensities for arrays probed with patient sera, healthy control sera or without serum sample (Negative). IL1B  IL32  TSLP  IL3  IL24  IL36B  IL20  IL26  IL12A  IL1RN  IL1F10  IL34  LIF  IL21  IL9  IL23A  IL16  IL25  IL4  IFNK  IL19  OSM  IL36G  IL13  CLCF1  IL10  IL7  IL2  IL15  IL5  IL27  IL17A  IL22  IFNA16  IFNW1  IL36A  IFNA17  IFNA1  IFNA13  IFNA4  IFNA21  IFNA2  IFNA5  IFNA6  IFNA8  IFNA14  IFNG  IL6  IL8   HC21 
Absolute correlation Table S1 . Prevalence of established autoantibodies in the protein array screen. 51 patients with APS1 were investigated. The upper limit of the normal range was defined as three standard deviations above the average of the healthy control subjects.
Gene
Tissue expression, mRNA seq (HPA)
TPH1
Group enriched (colon, duodenum, rectum, small intestine, stomach).
DDC
Tissue enhanced (duodenum, kidney, small intestine).
GAD2
Tissue enriched (cerebral cortex).
GAD1
IFNA13
Not detected.
IL22
GIF
Tissue enriched (stomach).
MAGEB2
Tissue enriched (testis).
MAGEB4
PDILT
Group enriched (stomach, testis).
TGM4
Tissue enriched (prostate). 
